Progress of anticancer drugs in reducing mortality from selected cancers in Europe

an assessment.

C. La Vecchia, F. Levi, F. Lucchini, S. Garattini

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Trends in mortality from four groups of cancers amenable to anti-cancer treatments (testicular cancer, Hodgkin's disease, leukemias and childhood cancers) between the late 1950s and the late 1980s were analyzed for the 23 larger European countries. In Western Europe, newer treatments led to the avoidance of approximately 1000 deaths from testicular cancer, 4000 from Hodgkin's disease, 4000 from leukemias, and 2500 from childhood cancers. In Eastern Europe, declines in mortality were observed only for childhood cancers, for a total of about 500 fewer deaths per year. Thus, approximately 11,000 deaths per year were avoided in Europe by newer cancer treatments, corresponding to 1% cancer deaths registered in the 23 larger European countries. A few thousand further deaths from these cancers could be avoided through more widespread and rational utilization of currently available therapies, particularly in Eastern Europe.

Original languageEnglish
Pages (from-to)215-221
Number of pages7
JournalAnti-Cancer Drugs
Volume2
Issue number3
Publication statusPublished - Jun 1991

Fingerprint

Mortality
Pharmaceutical Preparations
Neoplasms
Eastern Europe
Testicular Neoplasms
Hodgkin Disease
Leukemia
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pharmacology

Cite this

Progress of anticancer drugs in reducing mortality from selected cancers in Europe : an assessment. / La Vecchia, C.; Levi, F.; Lucchini, F.; Garattini, S.

In: Anti-Cancer Drugs, Vol. 2, No. 3, 06.1991, p. 215-221.

Research output: Contribution to journalArticle

@article{846338abb84441c78b86b30d74be3230,
title = "Progress of anticancer drugs in reducing mortality from selected cancers in Europe: an assessment.",
abstract = "Trends in mortality from four groups of cancers amenable to anti-cancer treatments (testicular cancer, Hodgkin's disease, leukemias and childhood cancers) between the late 1950s and the late 1980s were analyzed for the 23 larger European countries. In Western Europe, newer treatments led to the avoidance of approximately 1000 deaths from testicular cancer, 4000 from Hodgkin's disease, 4000 from leukemias, and 2500 from childhood cancers. In Eastern Europe, declines in mortality were observed only for childhood cancers, for a total of about 500 fewer deaths per year. Thus, approximately 11,000 deaths per year were avoided in Europe by newer cancer treatments, corresponding to 1{\%} cancer deaths registered in the 23 larger European countries. A few thousand further deaths from these cancers could be avoided through more widespread and rational utilization of currently available therapies, particularly in Eastern Europe.",
author = "{La Vecchia}, C. and F. Levi and F. Lucchini and S. Garattini",
year = "1991",
month = "6",
language = "English",
volume = "2",
pages = "215--221",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Progress of anticancer drugs in reducing mortality from selected cancers in Europe

T2 - an assessment.

AU - La Vecchia, C.

AU - Levi, F.

AU - Lucchini, F.

AU - Garattini, S.

PY - 1991/6

Y1 - 1991/6

N2 - Trends in mortality from four groups of cancers amenable to anti-cancer treatments (testicular cancer, Hodgkin's disease, leukemias and childhood cancers) between the late 1950s and the late 1980s were analyzed for the 23 larger European countries. In Western Europe, newer treatments led to the avoidance of approximately 1000 deaths from testicular cancer, 4000 from Hodgkin's disease, 4000 from leukemias, and 2500 from childhood cancers. In Eastern Europe, declines in mortality were observed only for childhood cancers, for a total of about 500 fewer deaths per year. Thus, approximately 11,000 deaths per year were avoided in Europe by newer cancer treatments, corresponding to 1% cancer deaths registered in the 23 larger European countries. A few thousand further deaths from these cancers could be avoided through more widespread and rational utilization of currently available therapies, particularly in Eastern Europe.

AB - Trends in mortality from four groups of cancers amenable to anti-cancer treatments (testicular cancer, Hodgkin's disease, leukemias and childhood cancers) between the late 1950s and the late 1980s were analyzed for the 23 larger European countries. In Western Europe, newer treatments led to the avoidance of approximately 1000 deaths from testicular cancer, 4000 from Hodgkin's disease, 4000 from leukemias, and 2500 from childhood cancers. In Eastern Europe, declines in mortality were observed only for childhood cancers, for a total of about 500 fewer deaths per year. Thus, approximately 11,000 deaths per year were avoided in Europe by newer cancer treatments, corresponding to 1% cancer deaths registered in the 23 larger European countries. A few thousand further deaths from these cancers could be avoided through more widespread and rational utilization of currently available therapies, particularly in Eastern Europe.

UR - http://www.scopus.com/inward/record.url?scp=0026167565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026167565&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 215

EP - 221

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 3

ER -